For the Inventor, By the Inventor

Enter assignee name

Cupertino, CA, United States of America

Reviva Pharmaceuticals, Inc.

USPTO Granted Patents = 27

CIPO Patents = 1

EPO Patents = 5

Trademarks = 1

Forward Citations = 45

Loading Chart...

Loading Chart...

7 inventors (with patents filed for the assignee):

Laxminarayan Bhat (27 out of 39 patents)

Kouacou Adiey (14 out of 15 patents)

Prabhu Prasad Mohapatra (13 out of 13 patents)

4. Seema Rani Bhat (11 out of 17 patents)

5. Ellen M Wallis (1 out of 1 patent)

6. Marc Cantillon (1 out of 1 patent)

7. Sureshbabu Dadiboyena (1 out of 1 patent)

27 patents: Sort by Forward Citations

1. 12053477 - Methods for treating pulmonary fibrosis (2024-08-06),

2. 10441590 - Methods for treating pulmonary hypertension (2019-10-15),

3. 9975862 - Arylpiperazine derivatives and methods of utilizing same (2018-05-22),

4. 9907803 - Methods for treating attention deficit hyperactivity disorder (2018-03-06),

5. 9695116 - Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives (2017-07-04),

6. 9604944 - Arylpiperazine derivatives and methods of utilizing same (2017-03-28),

7. 9302981 - Synthesis, methods of using, and compositions of cycloalkylmethylamines (2016-04-05),

8. 9296681 - Cycloalkylmethylamines (2016-03-29),

9. 9255076 - Arylpiperazine derivatives and methods of utilizing same (2016-02-09),

10. 9238625 - Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives (2016-01-19),

11. 9096515 - Methods of using cycloalkylmethylamine derivatives (2015-08-04),

12. 8980883 - Arylpiperazine derivatives and methods of utilizing same (2015-03-17),

13. 8859552 - Methods of utilizing arylpiperazine derivatives (2014-10-14),

14. 8669285 - Synthesis, methods of using, and compositions of cycloalkylmethylamines (2014-03-11),

15. 8604244 - Compositions, synthesis, and methods of using cycloalkylmethylamine derivatives (2013-12-10),

Reviva Pharmaceuticals, Inc. is a leading biopharmaceutical company focused on the discovery and development of innovative therapeutics for serious diseases. With a strong commitment to improving patient care, Reviva leverages its expertise in drug discovery and development to bring life-changing treatments to market. The company's pipeline includes potential therapies for various conditions, including cancer, neurodegenerative disorders, and cardiovascular diseases.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

27 Patents

#28 in Cupertino, CA

#2,849 in California

#12,008 in US

#23,292 in the World

Cupertino, CA, United States of America

Reviva Pharmaceuticals, Inc.

Forward Citations = 45

7 inventors:

Laxminarayan Bhat (27 out of 39 patents)

Kouacou Adiey (14 out of 15 patents)

Prabhu Prasad Mohapatra (13 out of 13 patents)

4. Seema Rani Bhat (11 out of 17 patents)

5. Ellen M Wallis (1 out of 1 patent)

Please report any incorrect information to support@idiyas.com

Loading…